FDG-PET imaging, EEG and sleep phenotypes as translational biomarkers for research in Alzheimer's disease

Biochemical Society Transactions

Volumn 39, Issue 4, 2011, Pages 874-880

  Platt, Bettina ^a   Welch, Andy ^a   Riedel, Gernot ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Alzheimer's disease (AD); Imaging; Positron emission tomography (PET); Power spectrum; Quantitative electroencephalogram; Sleep

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE F 18;

ALZHEIMER DISEASE; ANIMAL MODEL; APPARATUS; CELL CULTURE; CHOLINERGIC TRANSMISSION; CIRCADIAN RHYTHM; COGNITIVE DEFECT; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE COURSE; ELECTROENCEPHALOGRAPHY; EXPERIMENTAL MODEL; FAMILIAL DISEASE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENE OVEREXPRESSION; GLUCOSE METABOLISM; HUMAN; HYPERMETABOLISM; HYPOMETABOLISM; IN VIVO STUDY; NONHUMAN; NONREM SLEEP; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; REM SLEEP; SENSORIMOTOR FUNCTION; SLEEP; SYMPTOMATOLOGY; TRANSGENE; WAKEFULNESS;

ALZHEIMER DISEASE; ANIMALS; BIOLOGICAL MARKERS; CIRCADIAN RHYTHM; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; FLUORODEOXYGLUCOSE F18; HUMANS; MICE; MICE, TRANSGENIC; PHENOTYPE; POSITRON-EMISSION TOMOGRAPHY; SLEEP; TRANSLATIONAL RESEARCH;

ANIMALIA; RODENTIA;

EID: 79960852862     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0390874     Document Type: Conference Paper

References (50)

1. Morris, R.G., Moser, E.I., Riedel, G., Martin, S.J., Sandin, J., Day, M. and O'Carroll, C. (2003) Elements of a neurobiological theory of the hippocampus: the role of activity-dependent synaptic plasticity in memory. Philos. Trans. R. Soc. London Ser. B 358, 773-786
2. Humpel, C. (2011) Identifying and validating biomarkers for Alzheimer's disease. Trends Biotechnol. 29, 26-32
3. McGowan, E., Eriksen, J. and Hutton, M. (2006) A decade of modeling Alzheimer's disease in transgenic mice. Trends Genet. 22, 281-289
4. Weiner, M.W., Aisen, P.S., Jack, Jr, C.R., Jagust, W.J., Trojanowski, J.Q., Shaw, L., Saykin, A.J., Morris, J.C., Cairns, N., Beckett, L.A. et al. (2010) The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimer's Dement. 6, 202-211.e7
5. Woodruff-Pak, D.S. (2008) Animal models of Alzheimer's disease: therapeutic implications. J. Alzheimer's Dis. 15, 507-521
6. Epis, R., Gardoni, F., Marcello, E., Genazzani, A., Canonico, P.L. and Di Luca, M. (2010) Searching for new animal models of Alzheimer's disease. Eur. J. Pharmacol. 626, 57-63
7. Morrissette, D.A., Parachikova, A., Green, K.N. and LaFerla, F.M. (2009) Relevance of transgenic mouse models to human Alzheimer disease. J. Biol. Chem. 284, 6033-6037
8. Lee, V.M., Goedert, M. and Trojanowski, J.Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159
9. Oddo, S., Caccamo, A., Shepherd, J.D., Murphy, M.P., Golde, T.E., Kayed, R., Metherate, R., Mattson, M.P., Akbari, Y. and LaFerla, F.M. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Aβ and synaptic dysfunction. Neuron 39, 409-421 (Pubitemid 36937044)
10. Billings, L.M., Oddo, S., Green, K.N., McGaugh, J.L. and Laferla, F.M. (2005) Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45, 675-688 (Pubitemid 40320703)
11. Tampellini, D. and Gouras, G.K. (2010) Synapses, synaptic activity and intraneuronal Aβ in Alzheimer's disease. Front. Aging Neurosci. 2, 13
12. Magrane, J., Smith, R.C., Walsh, K. and Querfurth, H.W. (2004) Heat shock protein 70 participates in the neuroprotective response to intracellularly expressed β-amyloid in neurons. J. Neurosci. 24, 1700-1706 (Pubitemid 38240967)
13. Tomiyama, T., Matsuyama, S., Iso, H., Umeda, T., Takuma, H., Ohnishi, K., Ishibashi, K., Teraoka, R., Sakama, N., Yamashita, T. et al. (2010) A mouse model of amyloid β oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo. J. Neurosci. 30, 4845-4856
14. Meraz-Rios, M.A., Lira-De Leon, K.I., Campos-Pena, V., De Anda-Hernandez, M.A. and Mena-Lopez, R. (2010) Tau oligomers and aggregation in Alzheimer's disease. J. Neurochem. 112, 1353-1367
15. Sahara, N., Maeda, S., Murayama, M., Suzuki, T., Dohmae, N., Yen, S.H. and Takashima, A. (2007) Assembly of two distinct dimers and higher-order oligomers from full-length tau. Eur. J. Neurosci. 25, 3020-3029
16. Gama Sosa, M.A., De Gasperi, R. and Elder, G.A. (2010) Animal transgenesis: an overview. Brain Struct. Funct. 214, 91-109
17. Janus, C. (2008) Conditionally inducible tau mice: designing a better mouse model of neurodegenerative diseases. Genes Brain Behav. 7 (Suppl. 1), 12-27
18. Mayford, M., Bach, M.E., Huang, Y.Y., Wang, L., Hawkins, R.D. and Kandel, E.R. (1996) Control of memory formation through regulated expression of a CaMKII transgene. Science 274, 1678-1683 (Pubitemid 26414891)
19. Borchelt, D.R., Ratovitski, T., van Lare, J., Lee, M.K., Gonzales, V., Jenkins, N.A., Copeland, N.G., Price, D.L. and Sisodia, S.S. (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19, 939-945 (Pubitemid 27471397)
20. Platt, B. and Riedel, G. (2009) The first 3rd generation Alzheimer mouse, PLB1: design and development. Alzheimer's Dement. 5, P156
21. 18F]PET in mild and asymptomatic stages. Behav. Neurol. 21, 101-115
22. Klunk, W.E., Lopresti, B.J., Ikonomovic, M.D., Lefterov, I.M., Koldamova, R.P., Abrahamson, E.E., Debnath, M.L., Holt, D.P., Huang, G.F., Shao, L. et al. (2005) Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-β in Alzheimer's disease brain but not in transgenic mouse brain. J. Neurosci. 25, 10598-10606 (Pubitemid 41681907)
23. Willuweit, A., Velden, J., Godemann, R., Manook, A., Jetzek, F., Tintrup, H., Kauselmann, G., Zevnik, B., Henriksen, G., Drzezga, A. et al. (2009) Early-onset and robust amyloid pathology in a new homozygous mouse model of Alzheimer's disease. PLoS ONE 4, e7931
24. Jureus, A., Swahn, B.M., Sandell, J., Jeppsson, F., Johnson, A.E., Johnstrom, P., Neelissen, J.A., Sunnemark, D., Farde, L. and Svensson, S.P. (2010) Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand. J. Neurochem. 114, 784-794
25. Schulz, D., Southekal, S., Junnarkar, S.S., Pratte, J., Purschke, M.L., Stoll, S.P., Ravindranath, B., Maramraju, S.H., Krishnamoorthy, S., Henn, F.A. et al. (2011) Simultaneous assessment of rodent behavior and neurochemistry using a miniature positron emission tomograph. Nat. Methods 8, 347-352
26. Dukart, J., Mueller, K., Horstmann, A., Vogt, B., Frisch, S., Barthel, H., Becker, G., Moller, H.E., Villringer, A., Sabri, O. and Schroeter, M.L. (2010) Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies. Neuroimage 49, 1490-1495
27. Valla, J., Gonzalez-Lima, F. and Reiman, E.M. (2008) FDG autoradiography reveals developmental and pathological effects of mutant amyloid in PDAPP transgenic mice. Int. J. Dev. Neurosci. 26, 253-258
28. Figley, C.R. and Stroman, P.W. (2011) The role(s) of astrocytes and astrocyte activity in neurometabolism, neurovascular coupling, and the production of functional neuroimaging signals. Eur. J. Neurosci. 33, 577-588
29. Nicholson, R.M., Kusne, Y., Nowak, L.A., LaFerla, F.M., Reiman, E.M. and Valla, J. (2010) Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models. Brain Res. 1347, 179-185
30. 18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's disease. Mol. Imaging Biol. 11, 236-240
31. Luo, F., Rustay, N.R., Ebert, U., Hradil, V.P., Cole, T.B., Llano, D.A., Mudd, S.R., Zhang, Y., Fox, G.B. and Day, M. (2010) Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease. Neurobiol. Aging 221, 499-504
32. Platt, B. and Riedel, G. (2011) The cholinergic system, EEG and sleep. Behav. Brain Res. 221, 499-504
33. Brankack, J., Platt, B. and Riedel, G. (2009) Sleep and hippocampus: do we search for the right things? Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 806-812
34. McCarley, R.W. (2007) Neurobiology of REM and NREM sleep. Sleep Med. 8, 302-330
35. Jeong, J. (2004) EEG dynamics in patients with Alzheimer's disease. Clin. Neurophysiol. 115, 1490-1505
36. Iranzo, A., Molinuevo, J.L., Santamaria, J., Serradell, M., Marti, M.J., Valldeoriola, F. and Tolosa, E. (2006) Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol. 5, 572-577 (Pubitemid 43867426)
37. Jackson, C.E. and Snyder, P.J. (2008) Electroencephalography and event-related potentials as biomarkers of mild cognitive impairment and mild Alzheimer's disease. Alzheimer's Dement. 4 (Suppl. 1), S137-S143
38. Prichep, L.S. (2007) Quantitative EEG and electromagnetic brain imaging in aging and in the evolution of dementia. Ann. N.Y. Acad. Sci. 1097, 156-167
39. Jyoti, A., Plano, A., Riedel, G. and Platt, B. (2010) EEG, activity, and sleep architecture in a transgenic AβPPswe/PSEN1A246E Alzheimer's disease mouse. J. Alzheimer's Dis. 22, 873-887
40. Wisor, J.P., Edgar, D.M., Yesavage, J., Ryan, H.S., McCormick, C.M., Lapustea, N. and Murphy, Jr, G.M. (2005) Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: a role for cholinergic transmission. Neuroscience 131, 375-385
41. Zhang, B., Veasey, S.C., Wood, M.A., Leng, L.Z., Kaminski, C., Leight, S., Abel, T., Lee, V.M. and Trojanowski, J.Q. (2005) Impaired rapid eye movement sleep in the Tg2576 APP murine model of Alzheimer's disease with injury to pedunuclopontine cholinergic neurons. Am. J. Pathol. 167, 1361-1369
42. Plano, A., Jyoti, A., Wan, H., Reinhart, P., Riedel, G. and Platt, B. (2009) The first-third generation Alzheimer mouse, PLB1: EEG and activity behaviour. Alzheimer's Dement. 5 (Suppl.), P437
43. Lee, J.S., Im, D.S., An, Y.S., Hong, J.M., Gwag, B.J. and Joo, I.S. (2011) Chronic cerebral hypoperfusion in a mouse model of Alzheimer's disease: an additional contributing factor of cognitive impairment. Neurosci. Lett. 489, 84-88
44. Valla, J., Schneider, L. and Reiman, E.M. (2006) Age- and transgene-related changes in regional cerebral metabolism in PSAPP mice. Brain Res. 1116, 194-200 (Pubitemid 44485010)
45. Wang, J., Ikonen, S., Gurevicius, K., van Groen, T. and Tanila, H. (2002) Alteration of cortical EEG in mice carrying mutated human APP transgene. Brain Res. 943, 181-190 (Pubitemid 36120378)
46. Dubois, A., Herard, A.S., Delatour, B., Hantraye, P., Bonvento, G., Dhenain, M. and Delzescaux, T. (2010) Detection by voxel-wise statistical analysis of significant changes in regional cerebral glucose uptake in an APP/PS1 transgenic mouse model of Alzheimer's disease. Neuroimage 51, 586-598
47. Huitron-Resendiz, S., Sanchez-Alavez, M., Gallegos, R., Berg, G., Crawford, E., Giacchino, J.L., Games, D., Henriksen, S.J. and Criado, J.R. (2002) Age-independent and age-related deficits in visuospatial learning, sleep-wake states, thermoregulation and motor activity in PDAPP mice. Brain Res. 928, 126-137 (Pubitemid 34159059)
48. Sterniczuk, R., Dyck, R.H., Laferla, F.M. and Antle, M.C. (2010) Characterization of the 3xTg-AD mouse model of Alzheimer's disease. Part 1. Circadian changes. Brain Res. 1348, 139-148
49. Mugantseva, E.A. and Podolski, I.Y. (2009) Animal model of Alzheimer's disease: characteristics of EEG and memory. Cent. Eur. J. Biol. 4, 507-514
50. 18F-FDG- PET study. Alzheimer's Dement. 5 (Suppl.), P7